Buprenorphine treatment in an urban community health center: Wat to expect

Chinazo O. Cunningham, Angela Giovanniello, Galit Sacajiu, Susan Whitley, Pamela Mund, Robert S. Beil, Nancy Sohler

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Background: Despite new opportunities to expand buprenorphine treatment for opioid dependence, use of this treatment modality has been limited. Physicians may question their ability to successfully treat opioid-dependent patients with buprenorphine in a primary care setting. We describe a buprenorphine treatment program and treatment outcomes in an urban community health center. Methods: We conducted retrospective chart reviews on the first 41 opioid-dependent patients treated with buprenorphine/naloxone. The primary outcome was 90-day retention in treatment. Results: Patients' mean age was 46 years, 70.7% were male, 58.8% Hispanic, 31.7% black, 57.5% unemployed, and 70.0% used heroin prior to treatment. Twenty-nine (70.7%) patients were retained in treatment at day 90. Compared to those not retained, patients retained in treatment were more likely to have used street methadone (0% versus 37.9%) and less likely to have used opioid analgesics (54.6% versus 20.7%) and alcohol (50.0% versus 13.8%) prior to treatment. Of the 25 patients with urine toxicology tests, 24% tested positive for opioids. Conclusions: Buprenorphine treatment for opioid dependence in an urban community health center resulted in a 90-day retention rate of 70.7%. Type of substance use prior to treatment appeared to be associated with retention. These findings can help guide program development.

Original languageEnglish (US)
Pages (from-to)500-506
Number of pages7
JournalFamily Medicine
Volume40
Issue number7
StatePublished - Jul 2008

Fingerprint

Urban Health
Community Health Centers
Buprenorphine
Opioid Analgesics
Therapeutics
Program Development
Methadone
Heroin
Hispanic Americans
Toxicology
Primary Health Care
Alcohols
Urine

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Cunningham, C. O., Giovanniello, A., Sacajiu, G., Whitley, S., Mund, P., Beil, R. S., & Sohler, N. (2008). Buprenorphine treatment in an urban community health center: Wat to expect. Family Medicine, 40(7), 500-506.

Buprenorphine treatment in an urban community health center : Wat to expect. / Cunningham, Chinazo O.; Giovanniello, Angela; Sacajiu, Galit; Whitley, Susan; Mund, Pamela; Beil, Robert S.; Sohler, Nancy.

In: Family Medicine, Vol. 40, No. 7, 07.2008, p. 500-506.

Research output: Contribution to journalArticle

Cunningham, CO, Giovanniello, A, Sacajiu, G, Whitley, S, Mund, P, Beil, RS & Sohler, N 2008, 'Buprenorphine treatment in an urban community health center: Wat to expect', Family Medicine, vol. 40, no. 7, pp. 500-506.
Cunningham CO, Giovanniello A, Sacajiu G, Whitley S, Mund P, Beil RS et al. Buprenorphine treatment in an urban community health center: Wat to expect. Family Medicine. 2008 Jul;40(7):500-506.
Cunningham, Chinazo O. ; Giovanniello, Angela ; Sacajiu, Galit ; Whitley, Susan ; Mund, Pamela ; Beil, Robert S. ; Sohler, Nancy. / Buprenorphine treatment in an urban community health center : Wat to expect. In: Family Medicine. 2008 ; Vol. 40, No. 7. pp. 500-506.
@article{d1f9d31d4cf5438f84a3b212439e16df,
title = "Buprenorphine treatment in an urban community health center: Wat to expect",
abstract = "Background: Despite new opportunities to expand buprenorphine treatment for opioid dependence, use of this treatment modality has been limited. Physicians may question their ability to successfully treat opioid-dependent patients with buprenorphine in a primary care setting. We describe a buprenorphine treatment program and treatment outcomes in an urban community health center. Methods: We conducted retrospective chart reviews on the first 41 opioid-dependent patients treated with buprenorphine/naloxone. The primary outcome was 90-day retention in treatment. Results: Patients' mean age was 46 years, 70.7{\%} were male, 58.8{\%} Hispanic, 31.7{\%} black, 57.5{\%} unemployed, and 70.0{\%} used heroin prior to treatment. Twenty-nine (70.7{\%}) patients were retained in treatment at day 90. Compared to those not retained, patients retained in treatment were more likely to have used street methadone (0{\%} versus 37.9{\%}) and less likely to have used opioid analgesics (54.6{\%} versus 20.7{\%}) and alcohol (50.0{\%} versus 13.8{\%}) prior to treatment. Of the 25 patients with urine toxicology tests, 24{\%} tested positive for opioids. Conclusions: Buprenorphine treatment for opioid dependence in an urban community health center resulted in a 90-day retention rate of 70.7{\%}. Type of substance use prior to treatment appeared to be associated with retention. These findings can help guide program development.",
author = "Cunningham, {Chinazo O.} and Angela Giovanniello and Galit Sacajiu and Susan Whitley and Pamela Mund and Beil, {Robert S.} and Nancy Sohler",
year = "2008",
month = "7",
language = "English (US)",
volume = "40",
pages = "500--506",
journal = "Family Medicine",
issn = "0742-3225",
publisher = "Society of Teachers of Family Medicine",
number = "7",

}

TY - JOUR

T1 - Buprenorphine treatment in an urban community health center

T2 - Wat to expect

AU - Cunningham, Chinazo O.

AU - Giovanniello, Angela

AU - Sacajiu, Galit

AU - Whitley, Susan

AU - Mund, Pamela

AU - Beil, Robert S.

AU - Sohler, Nancy

PY - 2008/7

Y1 - 2008/7

N2 - Background: Despite new opportunities to expand buprenorphine treatment for opioid dependence, use of this treatment modality has been limited. Physicians may question their ability to successfully treat opioid-dependent patients with buprenorphine in a primary care setting. We describe a buprenorphine treatment program and treatment outcomes in an urban community health center. Methods: We conducted retrospective chart reviews on the first 41 opioid-dependent patients treated with buprenorphine/naloxone. The primary outcome was 90-day retention in treatment. Results: Patients' mean age was 46 years, 70.7% were male, 58.8% Hispanic, 31.7% black, 57.5% unemployed, and 70.0% used heroin prior to treatment. Twenty-nine (70.7%) patients were retained in treatment at day 90. Compared to those not retained, patients retained in treatment were more likely to have used street methadone (0% versus 37.9%) and less likely to have used opioid analgesics (54.6% versus 20.7%) and alcohol (50.0% versus 13.8%) prior to treatment. Of the 25 patients with urine toxicology tests, 24% tested positive for opioids. Conclusions: Buprenorphine treatment for opioid dependence in an urban community health center resulted in a 90-day retention rate of 70.7%. Type of substance use prior to treatment appeared to be associated with retention. These findings can help guide program development.

AB - Background: Despite new opportunities to expand buprenorphine treatment for opioid dependence, use of this treatment modality has been limited. Physicians may question their ability to successfully treat opioid-dependent patients with buprenorphine in a primary care setting. We describe a buprenorphine treatment program and treatment outcomes in an urban community health center. Methods: We conducted retrospective chart reviews on the first 41 opioid-dependent patients treated with buprenorphine/naloxone. The primary outcome was 90-day retention in treatment. Results: Patients' mean age was 46 years, 70.7% were male, 58.8% Hispanic, 31.7% black, 57.5% unemployed, and 70.0% used heroin prior to treatment. Twenty-nine (70.7%) patients were retained in treatment at day 90. Compared to those not retained, patients retained in treatment were more likely to have used street methadone (0% versus 37.9%) and less likely to have used opioid analgesics (54.6% versus 20.7%) and alcohol (50.0% versus 13.8%) prior to treatment. Of the 25 patients with urine toxicology tests, 24% tested positive for opioids. Conclusions: Buprenorphine treatment for opioid dependence in an urban community health center resulted in a 90-day retention rate of 70.7%. Type of substance use prior to treatment appeared to be associated with retention. These findings can help guide program development.

UR - http://www.scopus.com/inward/record.url?scp=48249141077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48249141077&partnerID=8YFLogxK

M3 - Article

C2 - 18928077

AN - SCOPUS:48249141077

VL - 40

SP - 500

EP - 506

JO - Family Medicine

JF - Family Medicine

SN - 0742-3225

IS - 7

ER -